rxstat › Shortages › Duloxetine

Duloxetine shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Duloxetine products are in shortage in Canada (4 of 32 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 10, 2026.
Products affected
4 / 32
In shortage since
Nov 4, 2025
Est. full return
Oct 10, 2026
Reports on file
127
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-DULOXETINE
60MG · CAPSULE (DELAYED RELEASE) · APOTEX INC
DIN 02440431 · since Nov 4, 2025, est. end Jul 3, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-DULOXETINE
60MG · CAPSULE (DELAYED RELEASE) · TEVA CANADA LIMITED
DIN 02456761 · since Jun 24, 2026, est. end Aug 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-DULOXETINE
30MG · CAPSULE (DELAYED RELEASE) · TEVA CANADA LIMITED
DIN 02456753 · since Jun 24, 2026, est. end Oct 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-DULOXETINE
60MG · CAPSULE (DELAYED RELEASE) · APOTEX INC
DIN 02440431 · since Dec 16, 2025, est. end Jun 12, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-DULOXETINE
60MG · CAPSULE (DELAYED RELEASE) · APOTEX INC
DIN 02440431 · since Feb 17, 2026, est. end Jun 12, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-DULOXETINE
30MG · CAPSULE (DELAYED RELEASE) · APOTEX INC
DIN 02440423 · since Dec 16, 2025, est. end Jun 12, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-DULOXETINE
30MG · CAPSULE (DELAYED RELEASE) · APOTEX INC
DIN 02440423 · since Feb 24, 2026, est. end Jun 5, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-DULOXETINE
30MG · CAPSULE (DELAYED RELEASE) · APOTEX INC
DIN 02440423 · since Dec 16, 2025, est. end Jun 5, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ DULOXETINE
30MG · CAPSULE (DELAYED RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02439948 · ended Sep 12, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ DULOXETINE
60MG · CAPSULE (DELAYED RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02439956 · ended Dec 12, 2025 · Disruption of the manufacture of the drug.
Resolved
M-DULOXETINE
60MG · CAPSULE (DELAYED RELEASE) · MANTRA PHARMA INC
DIN 02473216 · ended Nov 18, 2025 · Delay in shipping of the drug.
Resolved
SANDOZ DULOXETINE
60MG · CAPSULE (DELAYED RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02439956 · ended Sep 15, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Duloxetine is currently affected by 4 active shortage reports filed with Health Canada by APOTEX INC, TEVA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Duloxetine is classified under “ANTIDEPRESSANTS” (ATC N06AX).

Recent changes

Common questions

When will Duloxetine be back in stock in Canada?

The latest manufacturer estimate is Oct 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Duloxetine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antidepressants)

Widespread shortageClomipramine3 of 4 reported products affected · est. return Jul 3, 2026Widespread shortageImipramine3 of 6 reported products affected · est. return Aug 28, 2026Partial shortageAmitriptyline15 of 34 reported products affected · est. return Jul 17, 2026Partial shortageBupropion3 of 15 reported products affected · est. return Jul 15, 2026Partial shortageCitalopram10 of 43 reported products affected · est. return Sep 30, 2026Partial shortageDesvenlafaxine2 of 17 reported products affected · est. return Jul 31, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.